Gene expression signature of estrogen receptor alpha status in breast cancer
about
Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathwayGene expression profiling reveals new aspects of PIK3CA mutation in ERalpha-positive breast cancer: major implication of the Wnt signaling pathwayCDK9 directs H2B monoubiquitination and controls replication-dependent histone mRNA 3'-end processingEstrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cellsNF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivationIntegrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencingDerivation of molecular signatures for breast cancer recurrence prediction using a two-way validation approachDual-faced SH3BGRL: oncogenic in mice, tumor suppressive in humansDiscovering combinatorial interactions in survival dataSomatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence dataAn integrated analysis of genes and pathways exhibiting metabolic differences between estrogen receptor positive breast cancer cells.Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.The crystal structure of human Rogdi provides insight into the causes of Kohlschutter-Tönz SyndromeDiscovery and preclinical validation of drug indications using compendia of public gene expression data.A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer.Breast cancer biomarker discovery in the functional genomic age: a systematic review of 42 gene expression signatures.Identification and functional annotation of genome-wide ER-regulated genes in breast cancer based on ChIP-Seq data.Analysing breast cancer microarrays from African Americans using shrinkage-based discriminant analysis.A subset of histone H2B genes produces polyadenylated mRNAs under a variety of cellular conditions.Genes dysregulated to different extent or oppositely in estrogen receptor-positive and estrogen receptor-negative breast cancers.The role of the small GTPase Rab31 in cancer.The role of centrosomal Nlp in the control of mitotic progression and tumourigenesis.Multi-faceted quantitative proteomics analysis of histone H2B isoforms and their modifications.Arsenic, cadmium and neuron specific enolase (ENO2, γ-enolase) expression in breast cancer.High-throughput genomic technology in research and clinical management of breast cancer. Exploiting the potential of gene expression profiling: is it ready for the clinic?GATA3 protein as a MUC1 transcriptional regulator in breast cancer cells.Folate-Dependent Hydrolysis of Acetyl-Coenzyme A by Recombinant Human and Rodent Arylamine N-Acetyltransferases.Improved breast cancer prognosis through the combination of clinical and genetic markers.Rab31 expression levels modulate tumor-relevant characteristics of breast cancer cells.Genome-wide approaches for identification of nuclear receptor target genes.Differential network analysis reveals the genome-wide landscape of estrogen receptor modulation in hormonal cancersHigh expression of myoferlin is associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with HPV-statusEstrogen receptor (ER) beta or p53 attenuates ERalpha-mediated transcriptional activation on the BRCA2 promoter.Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts.Genetic ablation of caveolin-1 drives estrogen-hypersensitivity and the development of DCIS-like mammary lesions.Identification of gene expression signature in estrogen receptor positive breast carcinoma.Study of RNA Interference Targeting NET-1 Combination with Sorafenib for Hepatocellular Carcinoma Therapy In Vitro and In Vivo.Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications.Rhomboid domain containing 2 (RHBDD2): a novel cancer-related gene over-expressed in breast cancer.Identifying estrogen receptor target genes.
P2860
Q21093283-161EFB8B-C3C1-4390-9FE7-73B6E0708D43Q21135589-41BE48B9-009B-4650-AD76-CB8A7C90BC86Q24310547-97621A5A-6EDC-4A4F-B711-5783848EF9D9Q24319134-564427B1-F359-4112-99D8-63AC6F0E4139Q24653076-15D10B3A-1683-4BCD-A7F5-726A8281D0E9Q28742371-94D0ED11-4BC0-4E94-9BC2-D42052F54B9FQ28748329-6AE113C0-F164-4CD6-8B7C-EDDF73732C99Q30009087-35F8519A-C7BA-4C02-80AD-B34D2920C401Q30557494-76A3D82F-3EF5-442C-ABC0-87B521F069AEQ30823432-B15628E8-D3D7-4CF6-9FFF-9EF93C637D6FQ33299761-033C28A3-0C69-4535-A86A-88206B898936Q33416006-AB68D926-FD42-4EE8-9CCC-EE32EBC948A5Q33822617-BA0D68F9-8A18-4449-8F4E-3035DCA5D00EQ33995422-57964D7B-8DFA-4E54-9AE4-6C3A9DB24B8DQ34029272-C09698D0-6F7F-41B1-B71A-4B649D275DEFQ34300700-4C3DC16A-7262-4263-B7F2-DDF052C871D3Q34560737-39C7D08C-7E54-490B-A48A-14ACCB8A1149Q34592610-77BB96D8-E6AB-45C2-A47C-DF14B29BD34CQ34744482-419E0CC1-CA0B-4A7D-A524-83CFAC31995EQ34854816-1962DB51-7E59-4DCF-B88E-2CCBF334368FQ34885255-13A304C1-4F6D-4335-AC73-E073DDE61036Q35006781-C8BB3450-35A5-437F-9F1C-E3D02F6D0590Q35544839-3FA72605-0B9F-4660-BB82-3BD1C09FE018Q35600362-A723B44C-8170-4276-B563-A980F92A477FQ35605840-0CDE0A63-85AE-47C6-B5CB-345BE8FC7DAEQ35633697-E9D43E36-1E96-478A-A41C-789789032F9EQ35984967-E424CF00-7050-48B1-84D1-1FCBE0D2F194Q36201698-7D0AA26B-BCC2-4947-81E9-B28EA8BF6BECQ36403091-BE8535EC-17A4-4EFA-BDD3-FD9C7CD1F183Q36544557-020B5748-E8DB-4605-82FD-86C9E364AA69Q36682166-4C185338-BD17-44AB-88E6-3C7DBE0DA53CQ37109848-B5289AC2-4D7D-4C7C-8547-128D773A1C70Q37142529-64D0C7D3-4CF3-4038-8908-9CDECC7F019BQ37150735-ADF5881B-6D90-448D-9535-6BC5D9664A21Q37164504-0539BE3D-2655-4713-BE30-6173CBD828D9Q37198099-C27EF06A-E102-4AEC-BA2D-CDB82037C7AEQ37338222-093AFFBF-D614-4B4A-AD4A-9CF5FAF5465BQ37348421-6BB8C0C3-8E7E-4863-8BB8-8FF5D8F59F30Q37419573-22DE47BD-5DBE-4108-9F56-47E333CCA24CQ37453798-416FBAA5-B4A4-4949-9A8E-0E45374CC1B3
P2860
Gene expression signature of estrogen receptor alpha status in breast cancer
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Gene expression signature of estrogen receptor alpha status in breast cancer
@ast
Gene expression signature of estrogen receptor alpha status in breast cancer
@en
Gene expression signature of estrogen receptor alpha status in breast cancer
@nl
type
label
Gene expression signature of estrogen receptor alpha status in breast cancer
@ast
Gene expression signature of estrogen receptor alpha status in breast cancer
@en
Gene expression signature of estrogen receptor alpha status in breast cancer
@nl
prefLabel
Gene expression signature of estrogen receptor alpha status in breast cancer
@ast
Gene expression signature of estrogen receptor alpha status in breast cancer
@en
Gene expression signature of estrogen receptor alpha status in breast cancer
@nl
P2093
P2860
P356
P1433
P1476
Gene expression signature of estrogen receptor alpha status in breast cancer
@en
P2093
Aysegul Sahin
C Marcelo Aldaz
Hongxia Sun
Jeffrey A Drake
Keith Baggerly
Sally Gaddis
P2860
P2888
P356
10.1186/1471-2164-6-37
P407
P577
2005-01-01T00:00:00Z
P5875
P6179
1006938509